SAN DIEGO — Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, announced today that Dr. Paul R. Billings has been appointed to the Company’s Board of Directors. A board certified internist and clinical geneticist, Dr. Billings currently serves as Chief Medical Officer at Life Technologies Corporation and is a member of Trovagene’s Scientific […]
PALO ALTO, Calif. — Today Cellular Biomedicine Group (OTCQB: CBMG), announced that their A-StromalTM adipose stromal cell purification kit is ready to launch on the market in China. In addition, they have signed an exclusive China and Hong Kong license for ProCeller computer controlled processing system to extract stem cells from adipose tissue. These two […]
NEW YORK — The Enzo Clinical Labs subsidiary of Enzo Biochem, Inc. (NYSE:ENZ) has entered into an agreement to market in its northeast U.S. service area a proprietary early non-invasive prenatal laboratory test (“LDT”) service, MaterniT21 PLUS ™, developed by the Sequenom Laboratories, Inc., subsidiary of Sequenom, Inc. (NASDAQ:SQNM). “The addition of Sequenom Laboratories’ innovative […]
FRANKLIN LAKES, NJ – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, together with Direct Relief and the National Association of Community Health Centers (NACHC), today launched BD Helping Build Healthy CommunitiesSM, a four-year initiative that will expand access and improve care for underserved and vulnerable populations in the U.S. The […]
SAN DIEGO & VANCOUVER, British Columbia — Sophiris Bio Inc. (NASDAQ: SPHS) (TSX: SHS) today announced that enrollment has begun and the first patients have been dosed in a Phase 3 trial of PRX302 (topsalysin) as a treatment for lower urinary tract symptoms of benign prostatic hyperplasia (BPH or enlarged prostate). The Phase 3 international, […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced it has signed a definitive agreement to acquire Santa Clara-based NextBio, a leader in clinical and genomic informatics. NextBio’s powerful big-data platforms aggregate and analyze large quantities of phenotypic and genomic data for research and clinical applications. With the addition of NextBio’s platform upon completion of the […]
Today Definiens, the global leader in image analysis for digital pathology and diagnostics, announced the next step in its strategic roadmap for driving the clinical market for image analysis. Augmenting the earlier hiring of Ralf Huss as Chief Medical Officer, Definiens has added key business team members, Pablo Jordan and Rebecca Berghorn. “All experts point […]
Gilbertsville, PA — Rockland Immunochemicals Inc. today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Cancer Institute, National Institutes of Health (NCI/NIH) to develop nanoprobes for in vivo imaging of cancer cells and tumors that express one of the three important cancer therapeutic targets: EGFR, Her2 […]
BURLINGTON, N.C. — Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today the nationwide availability of QIAGEN’s therascreen® KRAS RGQ PCR Kit, a new FDA-approved companion diagnostic for certain colorectal cancer patients. The therascreen KRAS test is the only FDA-approved companion diagnostic for use with ERBITUX® (cetuximab), for patients with KRAS mutation-negative (wild type) […]
Study published in Translational Oncology highlights growing interest in non-invasive oncology diagnostics Fluxion Biosciences announced the publication of a paper entitled “Mutational Analysis of Circulating Tumor Cells Using a Novel Microfluidic Collection Device and qPCR Assay”, demonstrating the capability to detect mutations in circulating tumor cells (CTCs) from cancer patients. CTCs are cells that disseminate […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
